Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report

Johnson & Johnson, which in June opened a plant near WuHan, the epicenter of the outbreak in China, found that just getting product out of the region posed special difficulties, Chris Ewer, head of supply chain for Janssen Pharmaceuticals in the Asia-Pacific region, told the South China Morning Post.